This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr. Csaba Mera Named Regence Deputy Chief Medical Officer & Appointed To Oregon Patient Safety Commission

PORTLAND, Ore., April 9, 2013 /PRNewswire/ --  Regence is pleased to announce the appointment of Dr. Csaba Mera to the position of deputy chief medical officer. At the same time Dr. Mera has been appointed by the State of Oregon to the Oregon Patient Safety Commission.


Deputy Chief Medical DirectorWith a strong commitment to the improved health of Regence members, Dr. Mera has been charged with leading Regence's team of executive medical directors in Idaho, Utah and Washington, while maintaining his current role as the executive medical director of Regence BlueCross BlueShield of Oregon.

Regence's executive medical directors play a key role in establishing medical policy, improving quality health outcomes and lowering medical costs for Regence members. Dr. Mera's 25 years as a clinician coupled with nearly 20 years as a physician executive allows him a deep understanding of the total health care equation, to innovate and problem solve to the benefit of Regence members. Dr. Mera will report to Regence senior vice president of Health Care Services and chief medical officer, Dr. Richard Popiel.

"Dr. Mera's track record of improving the health of Regence members is clear. He's a committed partner, working with doctors, hospitals, and patients to find new and innovative ways to deliver care that keeps our members healthy, while reducing costs at the same time," said Dr. Popiel.

Oregon Patient Safety CommissionIt's this same dedication to quality care that led the state of Oregon to appoint Dr. Mera to the Oregon Patient Safety Commission. Working alongside leading doctors, nurses, educators and consumer advocates, Dr. Mera will partner to deliver on the Commission's goals of reducing preventable harm, implementing evidence-based best practices, and empowering providers and patients to achieve patient-centered care.

"In my current role with Regence, I am our members' chief advocate with providers. Our members expect that when they visit a doctor or hospital that they're receiving the best possible treatment," said Dr. Mera. "I'm eager to bring that same voice on behalf all Oregonians who demand and expect safe and effective care."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs